Skip to Content
New To Chronic Myeloid Leukemia? Get Information Today >>

Medications for Hemophilia B

What is Hemophilia B:  Hemophilia B is a hereditary blood coagulation disorder. It is caused by a deficiency of a blood plasma protein called factor IX. Without enough factor IX, the blood cannot clot properly to control bleeding.

Medications to treat Hemophilia B

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
BeneFix C N Add review
10

Generic name: coagulation factor ix systemic

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Profilnine SD C N Add review Rate

Generic name: factor ix complex systemic

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Alprolix C N Add review Rate

Generic name: coagulation factor ix systemic

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

 
Alphanine SD C N 1 review
9.0

Generic name: coagulation factor ix systemic

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Bebulin VH C N Add review Rate

Generic name: factor ix complex systemic

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

 
Mononine C N Add review Rate

Generic name: coagulation factor ix systemic

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Rixubis C N Add review Rate

Generic name: coagulation factor ix systemic

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

 
coagulation factor ix C N 1 review
9.0

Generic name: coagulation factor ix systemic

Brand names:  BeneFix, Alprolix, Alphanine SD, Mononine, Rixubis, Ixinity, Idelvion

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
factor ix complex C N Add review Rate

Generic name: factor ix complex systemic

Brand names:  Profilnine SD, Bebulin VH, Bebulin

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts

 
Bebulin C N Add review Rate

Generic name: factor ix complex systemic

For consumers: dosage, interactions, side effects

 
NovoSeven RT C N Add review Rate

Generic name: coagulation factor viia systemic

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Ixinity C N Add review Rate

Generic name: coagulation factor ix systemic

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Idelvion C N Add review Rate

Generic name: coagulation factor ix systemic

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph

 
coagulation factor viia C N Add review Rate

Generic name: coagulation factor viia systemic

Brand name:  NovoSeven RT

Drug class: miscellaneous coagulation modifiers

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 

Learn more about Hemophilia B

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide